BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32820348)

  • 1. The incidence of cutaneous squamous cell carcinoma in patients receiving voriconazole therapy for chronic pulmonary aspergillosis.
    Kosmidis C; Mackenzie A; Harris C; Hashad R; Lynch F; Denning DW
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2233-2237. PubMed ID: 32820348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients.
    Mansh M; Binstock M; Williams K; Hafeez F; Kim J; Glidden D; Boettger R; Hays S; Kukreja J; Golden J; Asgari MM; Chin-Hong P; Singer JP; Arron ST
    Am J Transplant; 2016 Jan; 16(1):262-70. PubMed ID: 26372838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
    D'Arcy ME; Pfeiffer RM; Rivera DR; Hess GP; Cahoon EK; Arron ST; Brownell I; Cowen EW; Israni AK; Triplette MA; Yanik EL; Engels EA
    JAMA Dermatol; 2020 Jul; 156(7):772-779. PubMed ID: 32401271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole.
    Feist A; Lee R; Osborne S; Lane J; Yung G
    J Heart Lung Transplant; 2012 Nov; 31(11):1177-81. PubMed ID: 22841559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk-adjusted relationship between voriconazole utilization and non-melanoma skin cancer among lung and heart/lung transplant patients.
    McLaughlin JM; Equils O; Somerville KT; Aram JA; Schlamm HT; Welch VL; Mardekian J; Barbers RG
    Transpl Infect Dis; 2013 Aug; 15(4):329-43. PubMed ID: 23489832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voriconazole exposure and risk of cutaneous squamous cell carcinoma among lung or hematopoietic cell transplant patients: A systematic review and meta-analysis.
    Tang H; Shi W; Song Y; Han J
    J Am Acad Dermatol; 2019 Feb; 80(2):500-507.e10. PubMed ID: 30130598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung transplant recipients receiving voriconazole and skin squamous cell carcinoma risk in Australia.
    Neoh CF; Snell GI; Levvey B; Kotsimbos T; Morrissey O; Slavin MA; Stewart K; Kong DC
    Med J Aust; 2014 Nov; 201(9):543-4. PubMed ID: 25358582
    [No Abstract]   [Full Text] [Related]  

  • 8. Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation.
    Kolaitis NA; Duffy E; Zhang A; Lo M; Barba DT; Chen M; Soriano T; Hu J; Nabili V; Saggar R; Sayah DM; DerHovanessian A; Shino MY; Lynch JP; Kubak BM; Ardehali A; Ross DJ; Belperio JA; Elashoff D; Saggar R; Weigt SS
    Transpl Int; 2017 Jan; 30(1):41-48. PubMed ID: 27678492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azathioprine to mycophenolate mofetil transition and risk of squamous cell carcinoma after lung transplantation.
    Vos M; Plasmeijer EI; van Bemmel BC; van der Bij W; Klaver NS; Erasmus ME; de Bock GH; Verschuuren EAM; Rácz E
    J Heart Lung Transplant; 2018 Jul; 37(7):853-859. PubMed ID: 29680587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nationwide Incidence of Metastatic Cutaneous Squamous Cell Carcinoma in England.
    Venables ZC; Autier P; Nijsten T; Wong KF; Langan SM; Rous B; Broggio J; Harwood C; Henson K; Proby CM; Rashbass J; Leigh IM
    JAMA Dermatol; 2019 Mar; 155(3):298-306. PubMed ID: 30484823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isavuconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A retrospective comparison of rates of adverse events.
    Bongomin F; Maguire N; Moore CB; Felton T; Rautemaa-Richardson R
    Mycoses; 2019 Mar; 62(3):217-222. PubMed ID: 30570179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voriconazole phototoxicity in children: a retrospective review.
    Sheu J; Hawryluk EB; Guo D; London WB; Huang JT
    J Am Acad Dermatol; 2015 Feb; 72(2):314-20. PubMed ID: 25481710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole.
    Cowen EW; Nguyen JC; Miller DD; McShane D; Arron ST; Prose NS; Turner ML; Fox LP
    J Am Acad Dermatol; 2010 Jan; 62(1):31-37. PubMed ID: 19896749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous squamous cell carcinoma in two pediatric lung transplant patients on prolonged voriconazole treatment.
    Wong JY; Kuzel P; Mullen J; Lien D; Mahmood M; Conrad C; Fiorillo L
    Pediatr Transplant; 2014 Sep; 18(6):E200-7. PubMed ID: 25039541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of voriconazole-induced cutaneous squamous cell carcinoma in Japan: data mining from different national pharmacovigilance databases.
    Tanaka H; Okuma M; Ishii T
    Pharmazie; 2022 Oct; 77(10):307-310. PubMed ID: 36273254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous cell carcinoma in an immunosuppressed patient on voriconazole.
    Carrascosa R; Solano-López GE; Vargas E; Fraga J
    Actas Dermosifiliogr; 2014 May; 105(4):424-6. PubMed ID: 24007811
    [No Abstract]   [Full Text] [Related]  

  • 17. Ten-Year Follow-up of Persons With Sun-Damaged Skin Associated With Subsequent Development of Cutaneous Squamous Cell Carcinoma.
    Madani S; Marwaha S; Dusendang JR; Alexeeff S; Pham N; Chen EH; Han S; Herrinton LJ
    JAMA Dermatol; 2021 May; 157(5):559-565. PubMed ID: 33760003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Cutaneous Squamous Cell Carcinoma (cSCC) In situ Incidence and the Risk of Developing Invasive cSCC in Patients With Prior cSCC In situ vs the General Population in the Netherlands, 1989-2017.
    Tokez S; Wakkee M; Louwman M; Noels E; Nijsten T; Hollestein L
    JAMA Dermatol; 2020 Sep; 156(9):973-981. PubMed ID: 32609322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients.
    Singer JP; Boker A; Metchnikoff C; Binstock M; Boettger R; Golden JA; Glidden DV; Arron ST
    J Heart Lung Transplant; 2012 Jul; 31(7):694-9. PubMed ID: 22484291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and timing of subsequent cutaneous squamous cell carcinoma in patients with cutaneous squamous cell carcinoma: A retrospective cohort study.
    Rodriguez M; Beal BT; Manmohan M; Simmons E; Varra V; Xiong D; Eversman A; Briskin IN; Knackstedt T; Vidimos AT
    J Am Acad Dermatol; 2021 Mar; 84(3):719-724. PubMed ID: 32861709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.